연구 결과에 따르면 세노바메이트를 부가요법으로 투여하였을 때 환자들의 발작 빈도가 위약 대비 현저하게 감소했다.
Studies had shown that when Cenobamate was administered on adjunctive therapy, the incidence of seizures in patients was significantly reduced compared to placebo.